dihexa human studies clinical trials status Dihexa shows neurotrophic activity exceeding BDNF in preclinical Post Hoc Analyses of DKD – Dihexa: Mechanism, Effects & Research

There is also a ClinicalTrials.gov listing for a phase 1 study described as assessing safety and pharmacokinetics of BPC-157 in healthy volunteers

Individuals with history of cancer or active malignancy should avoid BPC-157 until better safety data emerges

Grace ND, West DM, Sargison ND

Coordinate Comprehensive Care: Explore all possible treatment paths, combining traditional, proven methods with the responsible consideration of emerging therapies when appropriate for your individual needs

This approach balances therapeutic benefits against theoretical concerns about long-term continuous use, for which we lack human safety data